56 related articles for article (PubMed ID: 22452055)
1. [Anti-bacterial and anti-inflammatory actions of clarithromycin against Haemophilus influenzae that has infiltrated the respiratory epithelial cells].
Yamazaki Y; Tanabe T; Ushiki A; Kubo K
Jpn J Antibiot; 2009 Mar; 62 Suppl A():48-51. PubMed ID: 22452055
[No Abstract] [Full Text] [Related]
2. Susceptibility testing of Haemophilus influenzae to clarithromycin.
Paton R; Arnold J; Cockburn J; Emmanuel FX
J Antimicrob Chemother; 2000 Apr; 45(4):529-31. PubMed ID: 10747833
[TBL] [Abstract][Full Text] [Related]
3. Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A).
Seyama S; Wajima T; Suzuki M; Ushio M; Fujii T; Noguchi N
J Antimicrob Chemother; 2017 Mar; 72(3):948-949. PubMed ID: 27999037
[No Abstract] [Full Text] [Related]
4. Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice.
Nakamura S; Yanagihara K; Araki N; Yamada K; Morinaga Y; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Kamihira S; Kohno S
Antimicrob Agents Chemother; 2010 Feb; 54(2):757-62. PubMed ID: 19949056
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model.
Chen HY; Maskell JP; Powell M
J Antimicrob Chemother; 1992 May; 29(5):602-3. PubMed ID: 1385590
[No Abstract] [Full Text] [Related]
6. Azithromycin inhibits nontypeable Haemophilus influenzae-induced MUC5AC expression and secretion via inhibition of activator protein-1 in human airway epithelial cells.
Araki N; Yanagihara K; Morinaga Y; Yamada K; Nakamura S; Yamada Y; Kohno S; Kamihira S
Eur J Pharmacol; 2010 Oct; 644(1-3):209-14. PubMed ID: 20619258
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of methods for testing the susceptibility of Haemophilus influenzae to clarithromycin.
Barry AL; Schultheiss TS; Brown SD; Fuchs PC
J Antimicrob Chemother; 1996 Apr; 37(4):845-7. PubMed ID: 8722555
[No Abstract] [Full Text] [Related]
8. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
9. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
Morrissey I; Tillotson G
J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
[TBL] [Abstract][Full Text] [Related]
10. Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection.
Vallée E; Azoulay-Dupuis E; Swanson R; Bergogne-Bérézin E; Pocidalo JJ
J Antimicrob Chemother; 1991 Feb; 27 Suppl A():31-41. PubMed ID: 1827100
[TBL] [Abstract][Full Text] [Related]
11. [The activity of the macrolides on Haemophilus influenzae: a critical review].
Perea EJ
Med Clin (Barc); 1998 Feb; 110 Suppl 1():60-4. PubMed ID: 9717163
[No Abstract] [Full Text] [Related]
12. Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithromycin against Haemophilus influenzae using an in vitro pharmacodynamic model.
Garrison MW; Malone CL; Eiland J; Anderson DE
Diagn Microbiol Infect Dis; 1997 Apr; 27(4):139-45. PubMed ID: 9154410
[TBL] [Abstract][Full Text] [Related]
13. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
Soriano F; Fernández-Roblas R
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
[No Abstract] [Full Text] [Related]
14. Prevalence of anti-microbial resistance among respiratory isolates of Haemophilus influenzae.
Puri J; Talwar V; Juneja M; Agarwal KN; Gupta HC
Indian Pediatr; 1999 Oct; 36(10):1029-32. PubMed ID: 10745313
[No Abstract] [Full Text] [Related]
15. A clarithromycin sensitivity survey.
Rolinson GN
J Antimicrob Chemother; 1994 Sep; 34(3):444-5. PubMed ID: 7829420
[No Abstract] [Full Text] [Related]
16. Fluoroquinolone resistance in Haemophilus influenzae.
Elliott E; Oosthuizen D; Johnson MM; Piddock LJ
J Antimicrob Chemother; 2003 Oct; 52(4):734-5. PubMed ID: 12951328
[No Abstract] [Full Text] [Related]
17. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts.
Miyanohara T; Ushikai M; Matsune S; Ueno K; Katahira S; Kurono Y
Laryngoscope; 2000 Jan; 110(1):126-31. PubMed ID: 10646728
[TBL] [Abstract][Full Text] [Related]
18. Synergy testing of macrolide combinations using the chequerboard technique.
MacGowan AR; Bowker K; Bedford KA; Holt HA; Reeves DS
J Antimicrob Chemother; 1993 Dec; 32(6):913-5. PubMed ID: 8144439
[No Abstract] [Full Text] [Related]
19. In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae.
Kawakami Y; Okimura Y; Horiuchi N; Kanai M
Microbiol Immunol; 1982; 26(7):617-21. PubMed ID: 6290854
[No Abstract] [Full Text] [Related]
20. [Intrinsic resistance of Haemophilus influenzae to beta-lactam drugs].
Rodríguez-Avial C; Yáñez R; Rodríguez-Avial I; Picazo JJ
Med Clin (Barc); 1998 Feb; 110 Suppl 1():52-9. PubMed ID: 9717162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
